2022.08.03 18:35

Coherus BioSciences Shares Rise Premarket on FDA Approval of Lucentis Biosimilar >CHRS

By Colin Kellaher Shares of Coherus BioSciences Inc. jumped more than 10% in premarket trading on Wednesday after the biopharmaceutical company said the U.S....

The copyright of this article belongs to the original author/organization.
The current content only represents the author’s point of view, and has nothing to do with the position of Longbridge. The content is for investment reference only and does not constitute any investment advice. If you have any questions or suggestions about the content services provided by Longbridge, please contact: